IVOS Medical, Inc.
PrivateLast Round
Grant
Jan 22, 2025
Total Funding Raised
$2.15M
Momentum Score
25 /100
Company Overview
IVOS Medical, Inc. is a medical device company developing the BOSS G4™, a single-use video laryngoscope sheath designed to enhance safety and precision during intubations.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IVOS Medical, Inc. Comps
Public and private peers based on sector, stage, and business model.
IVOS Medical, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2025 | ||||
| Grant | Mar 17, 2022 | ||||
| Pre Seed | Jun 10, 2021 |
IVOS Medical, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Heart, Lung, and Blood Institute | Grant |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2025
$2M grant round completed.
- Jan 22, 2025
Announced the BOSS G4, a single-use video laryngoscope sheath.
IVOS Medical, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about IVOS Medical, Inc.'s valuation, stock price, and market status.
